These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

705 related items for PubMed ID: 30175895

  • 1. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
    Fujiwara C, Uehara A, Sekiguchi A, Uchiyama A, Yamazaki S, Ogino S, Yokoyama Y, Torii R, Hosoi M, Suto C, Tsunekawa K, Murakami M, Ishikawa O, Motegi SI.
    Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
    [Abstract] [Full Text] [Related]

  • 2. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J, Palumbo-Zerr K, Ruzehaji N, Tomcik M, Zerr P, Dees C, Distler A, Beyer C, Schneider H, Distler O, Schett G, Allanore Y, Distler JH.
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [Abstract] [Full Text] [Related]

  • 3. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
    Kanno Y, Kawashita E, Kokado A, Okada K, Ueshima S, Matsuo O, Matsuno H.
    Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
    [Abstract] [Full Text] [Related]

  • 4. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
    Soare A, Györfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, Ludolph I, Horch RE, Bäuerle T, von Hörsten S, Mihai C, Distler O, Ramming A, Schett G, Distler JHW.
    Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
    [Abstract] [Full Text] [Related]

  • 5. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A.
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of platelet-derived growth factor receptor-β signaling mediated by integrin-associated MFG-E8.
    Motegi S, Garfield S, Feng X, Sárdy M, Udey MC.
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2653-64. PubMed ID: 21868707
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of MFG-E8 after cutaneous ischemia-reperfusion injury.
    Uchiyama A, Yamada K, Perera B, Ogino S, Yokoyama Y, Takeuchi Y, Ishikawa O, Motegi SI.
    J Invest Dermatol; 2015 Apr; 135(4):1157-1165. PubMed ID: 25493650
    [Abstract] [Full Text] [Related]

  • 8. Expression of milk fat globule EGF-factor 8 (MFG-E8) mRNA and protein in the human endometrium and its regulation by prolactin.
    Franchi A, Bocca S, Anderson S, Riggs R, Oehninger S.
    Mol Hum Reprod; 2011 Jun; 17(6):360-71. PubMed ID: 21177637
    [Abstract] [Full Text] [Related]

  • 9. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M, Skaug B, Bi X, Mills T, Salazar G, Zhou X, Reveille J, Agarwal SK, Blackburn MR, Mayes MD, Assassi S.
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J, Palumbo K, Tomcik M, Zerr P, Dees C, Horn A, Maurer B, Akhmetshina A, Beyer C, Sadowski A, Schneider H, Shiozawa S, Distler O, Schett G, Allanore Y, Distler JH.
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [Abstract] [Full Text] [Related]

  • 11. MFG-E8 mediates arterial aging by promoting the proinflammatory phenotype of vascular smooth muscle cells.
    Chiang HY, Chu PH, Lee TH.
    J Biomed Sci; 2019 Aug 30; 26(1):61. PubMed ID: 31470852
    [Abstract] [Full Text] [Related]

  • 12. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M.
    Ann Rheum Dis; 2017 May 30; 76(5):924-934. PubMed ID: 28062404
    [Abstract] [Full Text] [Related]

  • 13. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
    Serratì S, Chillà A, Laurenzana A, Margheri F, Giannoni E, Magnelli L, Chiarugi P, Dotor J, Feijoo E, Bazzichi L, Bombardieri S, Kahaleh B, Fibbi G, Del Rosso M.
    Arthritis Rheum; 2013 Jan 30; 65(1):258-69. PubMed ID: 22972461
    [Abstract] [Full Text] [Related]

  • 14. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
    Del Galdo F, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, Jiménez SA.
    Arthritis Rheum; 2008 Sep 30; 58(9):2854-65. PubMed ID: 18759267
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S.
    Arthritis Rheum; 2010 Aug 30; 62(8):2476-87. PubMed ID: 20506342
    [Abstract] [Full Text] [Related]

  • 17. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M, Matsushita Y, Horikawa M, Higashi K, Tomigahara Y, Kaneko H, Shirasaki F, Fujimoto M, Takehara K, Sato S.
    Arthritis Rheum; 2009 Nov 30; 60(11):3465-75. PubMed ID: 19877032
    [Abstract] [Full Text] [Related]

  • 18. Role of milk fat globule-epidermal growth factor 8 in colonic inflammation and carcinogenesis.
    Kusunoki R, Ishihara S, Tada Y, Oka A, Sonoyama H, Fukuba N, Oshima N, Moriyama I, Yuki T, Kawashima K, Ansary MM, Tajima Y, Maruyama R, Nabika T, Kinoshita Y.
    J Gastroenterol; 2015 Aug 30; 50(8):862-75. PubMed ID: 25596854
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
    Zhang Y, Dees C, Beyer C, Lin NY, Distler A, Zerr P, Palumbo K, Susok L, Kreuter A, Distler O, Schett G, Distler JH.
    Ann Rheum Dis; 2015 May 30; 74(5):936-43. PubMed ID: 24431397
    [Abstract] [Full Text] [Related]

  • 20. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
    Wu M, Pedroza M, Lafyatis R, George AT, Mayes MD, Assassi S, Tan FK, Brenner MB, Agarwal SK.
    Arthritis Rheumatol; 2014 Apr 30; 66(4):1010-21. PubMed ID: 24757152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.